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ABSTRACT Plasmodium falciparum, the parasite that causes the deadliest form of
malaria, has evolved multiple proteins known as invasion ligands that bind to spe-
ciﬁc erythrocyte receptors to facilitate invasion of human erythrocytes. The EBA-175/
glycophorin A (GPA) and Rh5/basigin ligand-receptor interactions, referred to as in-
vasion pathways, have been the subject of intense study. In this study, we focused
on the less-characterized sialic acid-containing receptors glycophorin B (GPB) and
glycophorin C (GPC). Through bioinformatic analysis, we identiﬁed extensive varia-
tion in glycophorin B (GYPB) transcript levels in individuals from Benin, suggesting
selection from malaria pressure. To elucidate the importance of the GPB and GPC re-
ceptors relative to the well-described EBA-175/GPA invasion pathway, we used an ex
vivo erythrocyte culture system to decrease expression of GPA, GPB, or GPC via lenti-
viral short hairpin RNA transduction of erythroid progenitor cells, with global surface
proteomic proﬁling. We assessed the efﬁciency of parasite invasion into knockdown
cells using a panel of wild-type P. falciparum laboratory strains and invasion ligand
knockout lines, as well as P. falciparum Senegalese clinical isolates and a short-term-
culture-adapted strain. For this, we optimized an invasion assay suitable for use with
small numbers of erythrocytes. We found that all laboratory strains and the majority
of ﬁeld strains tested were dependent on GPB expression level for invasion. The col-
lective data suggest that the GPA and GPB receptors are of greater importance than
the GPC receptor, supporting a hierarchy of erythrocyte receptor usage in P. falci-
parum.
KEYWORDS Plasmodium falciparum, cultured erythrocyte, glycophorin, host cell
invasion, malaria, red blood cells, transcriptional variation
Malaria is a disease of major global health importance that is caused by parasitesof the genus Plasmodium, of which Plasmodium falciparum is the most virulent
(1). The asexual erythrocytic stage of the parasite life cycle is responsible for the
symptoms associated with malaria (1). A key step during this stage is parasite invasion
of erythrocytes mediated by interactions between parasite invasion ligands and their
cognate erythrocyte receptors, which deﬁne invasion pathways. Across Plasmodium
species, invasion ligands are grouped into two families: the Duffy binding-like or
erythrocyte binding-like (DBL/EBL) family and the reticulocyte binding-like (RBL) family
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(2–4). P. falciparum has four EBL ligands, i.e., EBA-175, EBL-1, EBA-140 (BAEBL), and
EBA-181 (JESEBL), and ﬁve RBL ligands, i.e., Rh1, Rh2a, Rh2b, Rh4, and Rh5. Of these, the
cognate receptors of ﬁve invasion ligands are known: glycophorin A (GPA), GPB, and
GPC, which bind EBA-175 (5), EBL-1 (6, 7), and EBA-140 (8, 9), respectively, and
complement receptor 1 (CR1) and basigin (BSG), which are receptors for Rh4 (10, 11)
and Rh5 (12), respectively.
Invasion pathways can be classiﬁed according to their dependence on the presence
of sialic acid on receptors; pathways involving the EBL invasion ligands and Rh1 are
reliant on sialic acid (sialic acid-dependent invasion pathways), while those involving
the remaining RBL ligands are not (sialic acid-independent invasion pathways). Al-
though P. falciparum has an extensive array of invasion pathways, not all are utilized at
the same time. The set of dominant invasion pathways used during invasion is strain
dependent and has led to a broad classiﬁcation of P. falciparum strains as sialic acid
dependent or independent. However, laboratory-adapted strains have the ability to
switch invasion pathway usage when speciﬁc receptors or determinants of interaction
are absent from the erythrocyte surface (13, 14). Furthermore, ﬁeld isolates commonly
utilize different sets of invasion pathways (15–19). The virulence of P. falciparum has
been partly attributed to its extensive set of invasion pathways, which enable it to
efﬁciently invade diverse host erythrocytes harboring different receptor polymor-
phisms.
Most recently, the Rh5/BSG sialic acid-independent invasion pathway has received
the greatest attention owing to the essentiality of the Rh5/BSG invasion pathway (12,
20). Other studies have also shown that the EBA-175/GPA sialic acid-dependent inva-
sion pathway plays a signiﬁcant role in both sialic acid-dependent and sialic acid-
independent strains (21–23). Importantly, naturally occurring anti-EBA-175 and anti-Rh5
invasion-inhibitory antibodies have been identiﬁed in individuals exposed to malaria
(24–27).
Less characterized are the EBA-140/GPC sialic acid-dependent invasion pathway (8,
9, 28, 29) and the sialic acid-dependent parasite invasion ligand EBA-181, for which no
receptor has been identiﬁed (30–32). The EBL-1/GPB invasion pathway has also been
poorly characterized, and there are contradictory reports regarding the importance of
GPB. One study reported a complete block in invasion of the sialic acid-independent
strain 7G8 into GPB-null (S-s-U-) erythrocytes (33), although a prior study showed little
inhibition of this strain (34). A subsequent study showed a 40 to 87% range in efﬁciency
of invasion into S-s-U- erythrocytes from ﬁve donors (35). Donor-to-donor blood group
differences and differences in receptors may contribute to the variable invasion phe-
notypes of GPB-null cells, which underscores a potential weakness of comparing
nonisogenic mutant and wild-type erythrocytes.
In a search for novel signatures of P. falciparum infection, we performed computa-
tional analysis of a published data set of transcriptomic proﬁles from malaria-infected
and healthy Beninese children (36), which led to the discovery that there is wide
variation in glycophorin B transcript (GYPB) transcript levels in healthy individuals. This
ﬁnding provided the impetus for a detailed study of the use of the GPB receptor in P.
falciparum invasion. In this study, we used an erythrocyte reverse genetics system (37)
to speciﬁcally knock down levels of expression of the sialic acid-dependent receptors
GPA, GPB, and GPC. We report that GPB is a key determinant of P. falciparum invasion.
RESULTS
GYPB transcript levels vary widely among healthy individuals in a region
where malaria is endemic. Erythrocyte receptors involved in P. falciparum invasion
and their regulatory regions harbor polymorphisms, some of which are overrepre-
sented in regions where malaria is endemic and are suggested to have arisen as a
consequence of the selective force of malaria on the human genome. To determine if
we could identify additional polymorphisms that might affect P. falciparum infection,
we performed computational analysis of transcriptional proﬁles generated from whole
blood of children in Benin, published by Idaghdour et al. (36). We ﬁrst deﬁned a subset
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of erythroid cell-speciﬁc genes from the transcriptome based on the HaemAtlas pub-
lished by the Bloodomics Consortium (38) and from known blood groups. Of 238
erythroid cell-speciﬁc/blood group transcripts from 61 healthy children included in the
analysis, we identiﬁed four genes with wide expression ranges (95 quantile to 5
quantile ratio larger than 10 and z score greater than 3): those for carbonic anhydrase
1 (CA1), hemoglobin zeta chain (HBZ), RAP1 GTPase-activating protein 1 (RAP1GAP),
and, unexpectedly, GYPB (Fig. 1A). Importantly, many transcripts with little variation
served as internal controls (Fig. 1A).
To determine if this GYPB transcript level variation translated to receptor expression
variation, we measured the levels of GPB, as well as GPA, GPC, and other blood group
receptors, in healthy donors in Senegal, where malaria is endemic, over two consecu-
tive years (Fig. 1B). The variation in surface expression of GPB in GPB-positive individ-
uals, estimated by the 95/5 quantile ratio, was 1.5-fold above background, much
smaller than the transcript level variation found in the Beninese children. We also
observed modest variation in surface expression of other receptors we measured, with
a 95/5 quantile ratio ranging from 1.2 to 3 (Fig. 1B).
Knockdown of GPA, GPB, or GPC in ex vivo cRBCs. To understand expression level
modulation of GPB in P. falciparum invasion and to determine the importance of this
receptor relative to the other major sialic acid-dependent receptors, GPA and GPC, we
knocked down expression of GPB in ex vivo cultured erythrocytes (cRBCs) via short
hairpin RNA (shRNA)-mediated gene silencing (37). In 6 or 7 independent experiments,
we achieved approximately 53.5%  8.9% (mean  standard deviation [SD]) knock-
down (KD) of GPA (P 0.001), 72.3% 14.2% KD of GPB (P 0.001), and 82.9% 6.5%
KD of GPC (P  0.001) (Fig. 2A and B), as determined by ﬂow cytometry. We also
measured the expression levels of all of the glycophorins (between three and seven
times) following KD of each receptor and found little change in the expression levels of
the others by ﬂow cytometry (Fig. 2B). We further measured surface expression by ﬂow
cytometry of other known Plasmodium receptors (BSG, band 3, CR1, and DARC) (see Fig.
S1 in the supplemental material). We observed a 4-fold increase in band 3 levels
following GPA KD, as previously reported (39), a 2-fold increase in BSG levels on GPA
KD cells, and an 25% decrease in BSG levels on GPB KD cells. Further, we found no
association between GPB and BSG levels by ﬂow cytometry in Senegalese individuals
(Fig. 1B). In addition, KD and pLKO control cRBCs had normal erythrocyte morphology
(Fig. 2C).
Global proteomic proﬁling to determine the level and speciﬁcity of GPA, GPB,
and GPC receptor knockdowns. To establish the similarity between cRBCs and
physiologically derived red blood cells (pRBCs), we measured expression of 78 cell
surface receptors by plasma membrane proﬁling (PMP) on cRBCs and pRBCs (see Table
S1 in the supplemental material). First, this analysis demonstrated the reticulocyte-like
nature of the cRBCs by showing that several proteins that decrease in abundance
during reticulocyte maturation, including CD71 (TFRC) (40, 41), CD36 (42, 43), ITGA4
(43), and SLC3A2 (44), were decreased in pRBCs relative to pLKO cRBCs (cluster 1) (Fig.
3A). The level of expression of proteins in cluster 2 remained unchanged between
pRBCs and pLKO cRBCs, while cluster 3 proteins were enriched on pRBCs and included
GPA and GPC. (By this method, we are unable to distinguish between GPA and GPB
peptides; thus, due to the 4-fold-greater abundance of GPA receptors, we assume
that the signal emanates from a GPA/GPB ratio of 4:1.)
We have calculated the numbers of molecules of known P. falciparum host receptors
per unit surface area (45–48, 50–52) (Table 1), using published values of the surface
areas of reticulocytes (142.4 2.0 m2) and pRBCs (133.6 3.0 m2) (45). We ﬁnd that
the surface densities of receptors on pLKO cells and pRBCs for all known receptors are
within 3-fold of each other, except for CR1, whose density is 5-fold lower on pLKO
cRBCs. GPA/GPB and GPC are found at lower levels on pLKO cells, while BSG is the only
major receptor that is found at a higher level. The lower density of GPA/GPB and GPC
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on pLKO cells suggests that further limitation of receptor densities by knockdown will
elicit receptor densities signiﬁcantly lower than those observed on pRBCs (Table 1).
To ensure that the speciﬁcity of invasion phenotypes would result speciﬁcally from
the receptors that were depleted, we made a comparison of pLKO and KD cRBCs. As
expected, GPA and GPC were reduced in the GPA and GPC KD cRBCs, respectively
FIG 1 Glycophorin B transcript level variation and erythrocyte receptor expression among individuals in regions where malaria is
endemic. (A) Graph highlighting transcripts, including GYPB, whose abundance varied widely among erythroid cell-speciﬁc transcripts
from 61 healthy individuals in Benin. Bioinformatic analysis was based on the whole blood transcriptomics study of malaria-infected
and healthy children in Benin (36). (B) Expression of GPB and other erythrocyte receptors from blood of healthy Senegalese donors
in 2011 (left graph) and 2012 (right graph). The graphs show the 95/5 quantile ratio normalized to the quantile ratio for a control
secondary antibody (Ab). The quantile ratio was based on mean ﬂuorescence intensity values determined by ﬂow cytometry. In 2011,
measurements were made on RBCs from 29 donors (GPB), 32 donors (CD55 and CR1), or 41 donors (RhD), and in 2012, they were made
on RBCs from 11 donors (GPB) or 29 donors (all other receptors). In 2011, one GPB-null individual and three RhD-null individuals were
observed but were excluded from measurement of the 95/5 quantile ratio. In 2012, three different probes were used to measure
expression of GPA and GPC (see Materials and Methods).
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(Fig. 3B and D). As mentioned above, GPA and GPB peptides are indistinguishable;
therefore, GPB depletion in the GPB KD cells was not observable by this analysis. Of all
the known receptors considered, only BSG levels were reduced (albeit at borderline
signiﬁcance [P  0.047]) (Table S1 and Fig. 3C) in GPB KD cells. Calculated surface
densities of BSG on GPB KD cells are comparable to those found on pRBCs (Table 1),
suggesting that BSG is not limited to levels that would contribute to an invasion
phenotype. This analysis also revealed other proteins that have signiﬁcantly altered
levels in pLKO cRBCs relative to KD cRBCs (Fig. 3B to D; see Table S2 in the supplemental
material). To date, no role in invasion has been described for these proteins.
Interestingly, band 3 (SLC4A1) levels were not signiﬁcantly elevated by proteomic
analysis on GPA KD cells (Fig. 3B), in contrast to the signiﬁcant increase in band 3 levels
determined by ﬂow cytometry (Fig. S1) (37). One potential explanation for the discrep-
ancy is that knockdown of GPA (known to be in a complex with band 3 [53, 54])
improves accessibility of the band 3 antibody to its epitope during ﬂow cytometry
measurements.
A scaled-down assay for measuring erythrocyte invasion efﬁciency. To enable
us to assess the invasion proﬁles of as many P. falciparum strains as possible, we
developed a scaled-down invasion assay that makes use of small numbers of cells of
interest (Fig. 4A). In our assay design, a P. falciparum culture treated with neuraminidase
(Nm), trypsin, and chymotrypsin, constituting donor cells, is added to cells of interest
(acceptor cells) in an 80:20 ratio, and parasitemia is determined after a single round of
invasion. We used the 80:20 ratio of donor to acceptor cells over other ratios because
the 80:20 ratio allowed us to use a limited number of cultured erythrocytes yet gave us
a reasonable, measurable ﬁnal parasitemia of 3% when assessing invasion of 3D7 into
pLKO control cells with a starting parasitemia of 2% (Fig. 4B). The success of this
scaled-down assay depends on effective treatment with neuraminidase, trypsin, and
FIG 2 Knockdown of glycophorins A, B, and C in cultured erythrocytes. (A) Expression of glycophorin A (GPA), glycophorin B (GPB), and glycophorin C (GPC)
on the cell surface of GPA knockdown (KD) (green), GPB KD (blue), and GPC KD (pink) cultured erythrocytes (cRBCs) as determined by ﬂow cytometry.
Representative ﬂow cytometry plots are shown. Gray traces, receptor expression on pLKO cRBCs; dashed traces, pLKO cells stained with a control antibody. (B)
Mean expression standard error from three to seven independent experiments, normalized to expression on pLKO cells. For measurement of GPB expression,
cRBCs were treated with trypsin to remove GPA and cells stained with a GPA/B antibody. Statistical signiﬁcance was determined using a one-way analysis of
variance (ANOVA) with a Dunnett multiple-comparison test. ***, P  0.001. (C) May-Grünwald- and Giemsa-stained cytospins showing normal morphology of
KD and pLKO control cRBCs. cRBCs were passed through a 5-m ﬁlter to remove nucleated cells prior to ﬂow cytometry and cytospin preparation.
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chymotrypsin to prevent reinvasion into donor cells, careful counting of acceptor cells
(achieved with a hemocytometer), and a reasonable starting parasitemia in the donor
culture (ideally 2.5%), since only 20% of the cells in each sample have intact receptors
for invasion.
GPB is a major receptor used by P. falciparum laboratory strains. To assess the
relative importance of GPB in invasion, we tested invasion of KD cRBCs by a panel of
FIG 3 Quantitative cell surface proteomics of peripheral erythrocytes and cultured erythrocytes. (A) Quantitative cell
surface proteomic comparison between pLKO cRBCs and peripheral RBCs (pRBCs). k-means clustering analysis of the 78
surface membrane proteins identiﬁed three clusters: cluster 1, proteins that decrease between pLKO cRBCs and pRBCs;
cluster 2, proteins that remain at the same level between pLKO cRBCs and pRBCs; and cluster 3, proteins that increase
between pLKO cRBCs and pRBCs. The scale bar represents the normalized relative abundance of each protein. Note that
the peptides detected by this technique did not allow a distinction to be made between GPA and GPB. (B to D) Comparison
of the relative abundances of membrane proteins between the pLKO control cRBCs and either the GPA KD cRBCs (B), GPB
KD cRBCs (C), or GPC KD cRBCs (D). Fold change was calculated as the ratio of the signal/noise ratio for GPA/B/C KD) to
the average signal/noise for the pLKO control. y axes show the average signal/noise (S:N) ratio across all samples. P values
were estimated using Benjamini-Hochberg-corrected signiﬁcance A, calculated in Perseus v 1.5.1.6.
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wild-type P. falciparum laboratory-adapted strains and invasion ligand deletion strains.
Using our scaled-down invasion assay, we observed decreased invasion of the sialic
acid-dependent strain Dd2 into GPB KD cRBCs (56.4%  24.2% [mean  SD]) as well
as GPA KD cRBCs (72.9%  18.3%), as previously reported (37), but no change in
invasion of GPC KD cells (91.8%  8.2%) relative to pLKO control cells (Table 2).
It has been shown that strain 3D7 uses the sialic acid-dependent EBA-175/GPA
invasion pathway to some extent (23). We did not observe a decrease in invasion of 3D7
into GPA KD cRBCs, consistent with a previous report (37); however, the parent 3D7
TABLE 1 Comparison of copies of known P. falciparum host receptors per unit surface area on peripheral erythrocytes and cultured
erythrocytesa
Protein (reference[s])
No. of copies/m on erythrocyte type:
pRBC pLKO GPA KD GPB KD GPC KD
GPA (48, 50, 52) 7.49  103 4.42  103 1.25  103 1.62  103 2.38  103
GPB (48, 50, 52) 1.87  103 1.11  103 3.11  102 4.05  102 5.95  102
GPC (48, 50, 51) 7.49  102 2.57  102 1.52  102 1.62  102 9.51  101
BSG (47, 50) 2.25  101 6.26  101 8.72  101 2.21  101 6.52  101
CR1 (50) (1.50–8.98)  100 (0.31–1.84)  100 (0.41–2.43)  100 (0.38–2.31)  100 (0.52–3.13)  100
Band 3 (47) 7.49  103 3.53  103 4.68  103 1.97  103 3.26  103
Kx (47) 7.49  100 8.81  100 1.05  101 7.04  100 8.36  100
CD55 (47) 1.50  102 1.59  102 1.49  102 9.47  101 1.42  102
CD44 (46, 47) 2.62  101 4.47  101 6.66  101 3.05  101 3.64  101
aThe reported numbers of copies of known P. falciparum host receptors on peripheral erythrocytes (pRBCs) were used to estimate the numbers of copies of host
receptors on pLKO cRBCs based on the normalized signal/noise ratios from quantitative surface proteomics and the following reported surface areas for mature RBCs
of 133.6  3.0 m2 and for reticulocytes of 142.4  2.0 m2 (45), which we assume to be representative of pLKO cRBCs. Since GPA and GPB peptides are
indistinguishable by surface proteomics, estimation was based on the reported relative abundance of GPA and GPB on pRBCs. The densities of host receptors per
unit surface area for GPA, GPB, and GPC are within 3-fold lower on pLKO cRBCs than on pRBCs.
FIG 4 Schematic of invasion assay design. (A) A ring-stage parasite culture is treated with neuraminidase,
trypsin, and chymotrypsin (NTC), returned to culture conditions, and allowed to mature to the late
trophozoite (troph) or schizont stage. The treated culture (donor cells) is mixed in an 80:20 ratio with
either knockdown (KD) or control pLKO cRBCs (acceptor cells). Initial parasitemia and/or ﬁnal parasitemia
after one round of invasion are determined either by microscopy from counts of 500 to 2,000 erythro-
cytes or by ﬂow cytometry of SYBR green I-stained cells. Invasion assays are set up at 0.5% hematocrit.
All acceptor cells are counted by hemocytometer prior to assay setup. (B) Invasion of P. falciparum 3D7
treated with neuraminidase, trypsin, and chymotrypsin into pLKO control cRBCs with various ratio of
enzyme-treated donor cells to pLKO acceptor cells. A 100:0 ratio indicates treated 3D7 donor cells and
no pLKO cRBCs. Initial parasitemia was 2%. Final parasitemia was determined by ﬂow cytometry of
SYBR green I-stained cells. The assay was performed once in duplicate. Bars represent the mean  the
range. The 80:20 ratio was selected for subsequent invasion assays. E, expected parasitemia based on
invasion into a 50:50 mixture. O, observed parasitemia.
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strain and the derived invasion ligand deletion lines, 3D7ΔEBA-175 and 3D7ΔRh2b, had
decreased invasion into GPB KD cRBCs (Table 2). This decrease reached statistical
signiﬁcance for 3D7 (66.6%  23.3%) and 3D7ΔRh2b (60.5%  26.6%), indicating that
in 3D7, the GPB receptor is more important than the GPA receptor. None of the 3D7
strains showed decreased invasion into GPC KD cRBCs (Table 2), suggesting a lesser role
in invasion for this receptor.
Like 3D7, the sialic acid-independent strains 7G8 and HB3 showed decreased
invasion of GPB KD cells, though this decrease was not statistically signiﬁcant (Table 2).
We did not observe decreased invasion of 7G8 or HB3 into GPA or GPC KD cRBCs
relative to pLKO cRBCs. Altogether, our data suggest that GPB is important for invasion
by the tested sialic acid-dependent and sialic acid-independent laboratory strains of P.
falciparum.
Many P. falciparum ﬁeld isolates use GPB for invasion. To determine whether
GPB is important in invasion by ﬁeld isolates, we assessed invasion of a culture-adapted
Senegalese isolate and fresh clinical isolates from Senegal into KD cRBCs (Tables 2 and
3). Sen51, a short-term culture-adapted strain which was sensitive to Nm treatment
(deﬁned as efﬁciency of invasion of less than 60% into Nm-treated pRBCs that are
devoid of sialic acid [see Table S3 in the supplemental material]), showed decreased
invasion into GPB KD cRBCs (58.8%  16.8% [mean  SD]) but not into GPA KD cRBCs
(109.7%  28.3%) or GPC KD cRBCs (113.0%  3.6%) (Table 2).
For invasion by fresh clinical isolates, ﬁve out of eight strains had less than 60%
invasion into GPB KD cRBCs as well as GPA KD cRBCs, while none of the ﬁve had less
than 60% invasion into GPC KD cRBCs relative to pLKO cRBCs (Table 3). Of these ﬁve
isolates, three were sensitive to Nm-treated pRBCs (Th303, Th305, and Th306), while
TABLE 2 Efﬁciencies of invasion of P. falciparum laboratory-adapted strains and a
Senegalese culture-adapted isolate into knockdown cultured erythrocytes
Strain
% efﬁciency of invasiona into erythrocyte type:
GPA KD GPB KD GPC KD
Dd2 72.9 18.3* 56.4 24.2** 91.8 8.2
3D7 90.2 11.4 66.6 23.3*** 89.6 9.8
3D7ΔEBA175 100.4 31.8 53.4 30.0 94.1 16.5
3D7ΔRh2b 101.2 14.8 60.5 26.6* 100.2 4.8
7G8 85.0 31.5 56.1 26.8 98.3 21.9
HB3 101.3 43.7 53.6 18.1 93.0 15.5
Sen51 109.7 28.3 58.8 16.8* 113.0 3.6
aEfﬁciency of invasion into KD cells relative to pLKO control cells, based on ﬁnal parasitemia. Parasitemia was
determined by microscopy from counts of 500 to 2,000 erythrocytes, depending on the experiment.
Invasion assays were performed in triplicate, four to six times for 3D7, Dd2, 7G8, and HB3 and three times
for 3D7ΔEBA-175, 3D7ΔRh2b, and Sen51. Shown are the means and standard deviations. Statistical
signiﬁcance was determined using a one-way ANOVA with a Dunnett multiple-comparison test (*, P  0.05;
**, P  0.01; and ***, P  0.001).
TABLE 3 Efﬁciency of invasion of P. falciparum ex vivo ﬁeld isolates into knockdown
cultured erythrocytes
Strain
% efﬁciency of invasiona into erythrocyte type:
GPA KD GPB KD GPC KD
Th266 88.7 12.1 66.2 14.2 52.5 16.4
Th268 100.9 28.1 79.1 17.8 54.8 9.4
Th275 110.4 60.7 118.0 66.4 70.9 10.0
Th303 39.0 4.1 55.6 4.6 69.1 2.5
Th304 40.7 1.6 56.0 4.7 92.3 24.9
Th305 30.6 0 36.7 5.8 86.7 10.1
Th306 44.9 0.1 47.6 16.5 93.5 42.2
Th312 28.5 3.5 51.7 10.1 91.8 2.0
aEfﬁciency of invasion into KD cells relative to pLKO control cells, based on ﬁnal parasitemia. Parasitemia was
determined by microscopy from counts of 800 to 1,000 erythrocytes. Invasion assays were performed once,
in triplicate (Th266, Th268, and Th275) or duplicate (Th303, Th304, Th305, Th306, and Th312). Errors indicate
the standard deviation (Th266, Th268, and Th275) or the range (Th303, Th304, Th305, Th306, and Th312).
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two were resistant (Th304 and Th312). Two other isolates which had decreased invasion
only into GPC KD cRBCs were sensitive to Nm-treated pRBCs (Th266 and Th268),
bringing the proportion of Nm-sensitive strains to 75% (six out of eight strains).
Invasion into GPB KD cells ranged from 36.7%  5.8% to 118.0%  66.4%, while the
range for GPA KD cells was 28.5%  3.5% to 110.4%  60.7% and that for GPC KD cells
was 52.5%  16.4% to 93.5%  42.2% (Table 3). Overall, our results indicate that for
ﬁeld isolates, GPB is of comparable importance in invasion as GPA and is more utilized
than GPC for most strains tested, though there is more heterogeneity in receptor usage
for ﬁeld isolates than for lab lines. Furthermore, there is not a simple relationship
between sialic acid dependence and the phenotype of invasion into KD cRBCs.
DISCUSSION
In this study, we have used erythrocyte reverse genetics in an isogenic background
to speciﬁcally and comparatively assess the use of three major sialylated erythrocyte
receptors, GPA, GPB, and GPC, in invasion of erythrocytes by P. falciparum laboratory-
adapted and ﬁeld strains. We used genetically altered cRBCs to evaluate the contribu-
tion of speciﬁc invasion ligands in isogenic cells in ex vivo parasite invasion assays. This
contrasts with previous studies, which depended on enzyme-treated cells and noniso-
genic naturally occurring mutant erythrocytes to reveal invasion pathways (39). The
cRBCs used in this study express the full complement of P. falciparum receptors and
are of a relatively homogeneous age, though their reticulocyte-like nature results in
some differences in surface receptor abundance relative to that of pRBCs. Never-
theless, we achieved limiting numbers of receptors on KD cells, enabling us to
determine the relative importance of speciﬁc receptors. In comparing invasion into
GPA, GPB, and GPC KD cells, we observed a dependence on GPB by both sialic
acid-dependent and sialic acid-independent laboratory strains; this reliance on GPB
was greater than that on GPA, which is used by many laboratory strains regardless of
sialic acid dependence (21, 23). Our data also suggest that the GPC receptor is less
important for invasion in most strains tested.
Bioinformatic analysis of transcriptional proﬁles of Beninese children revealed a wide
variation in GYPB transcript levels, and one factor that might contribute to this is GYPB
genetic polymorphisms in Africans. A high prevalence of the GPB-null genotype exists
in regions where malaria is endemic and among individuals of African descent (ranging
from 2 to 8% in West Africa to as high as 59% among the Efe pygmies in the Democratic
Republic of Congo [55, 56]), suggesting that malaria pressure selected for this
polymorphism. The Dantu variant of GPB, representing a hybrid GPA-GPB molecule
with a GPB N-terminal region and a GPA C-terminal region, has been shown to
confer protection against invasion and growth of P. falciparum in vitro (57). A recent
study has found evidence for a strong protective effect of the Dantu NE genotype
against cerebral malaria and severe malaria anemia in East Africa (56). The Dantu NE
genotype, which results from an intricate structural modiﬁcation of the GYPE-GYPB-
GYPA locus, including deletion of the 3= end of GYPB, was found to have arisen recently
in Kenya. In addition to the Dantu variant, those authors identiﬁed multiple examples
of deletions and duplications at the GYPE-GYPB-GYPA locus. In our study, we did not
observe variation in GPB surface expression in healthy Senegalese to the same extent
as that seen for transcript levels in Beninese individuals, suggesting that GYPB tran-
script level differences do not directly reﬂect surface receptor expression. Alternatively,
it is possible that there are country-speciﬁc differences in GYPB polymorphisms, such
that Beninese but not Senegalese individuals exhibit GYPB transcript level variation
with concomitant variation in surface expression levels. Further investigation is re-
quired to understand the origin and signiﬁcance of GYPB variation.
The observation from this work that GPB is an important receptor for P. falciparum
invasion is at odds with work showing that some laboratory-adapted strains (58, 59)
and ﬁeld isolates from Kenya (60) and Columbia and Peru (61) have either an ebl-1 gene
deletion, a thymidine insertion, or a premature stop codon that results in a truncated
EBL-1 product. Prior to these ﬁndings, some of the studies that had reported use of the
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EBL-1/GPB invasion pathway had used P. falciparum strains that have a mutated or
deleted ebl-1 gene, for example, 7G8, 3D7, or HB3 (33, 35), suggesting that perhaps
there is an additional parasite ligand that binds to GPB. In this study, we observed
usage of GPB by laboratory strains that are reported to lack a functional EBL-1 ligand,
i.e., 7G8 and 3D7 (59) and HB3 (58), further suggesting that there is an additional
parasite ligand for GPB. Such a ligand may have features in common with the other P.
falciparum invasion ligands that bind glycophorins (EBA-175, EBL-1, and EBA-140), such
as a DBL-like domain.
Importantly, our work demonstrates that many ﬁeld strains use GPB for invasion.
Given this dependence on GPB in a region with GPB-null prevalence, it would be
relevant to genotype ﬁeld isolates to determine if there are any mutations in ebl-1, as
has been noted in some ﬁeld isolates in Kenya (60) and Columbia and Peru (61), and in
the absence of inactivating mutations, to determine whether invasion-inhibitory EBL-1
antibodies exist in the Senegalese population. Identifying an alternate invasion ligand
that binds to GPB would warrant assessing usage by ﬁeld isolates and determining the
ability of naturally acquired antibodies against this ligand to block invasion, which may
lead to consideration of this ligand for inclusion in an invasion-blocking subunit
vaccine.
Eight of the nine ﬁeld strains in this study showed decreased invasion into GPA, GPB,
and/or GPC KD cells, emphasizing the sialic acid-dependent nature of many Senegalese
strains. We also found that several ﬁeld isolates had decreased invasion into Nm-treated
pRBCs, consistent with previous ﬁeld studies reporting decreased invasion of Nm-
treated pRBCs (15, 18, 26, 62). However, we did not ﬁnd a simple concordance between
decreased invasion into GPA, GPB, and GPC KD cRBCs and sialic acid dependence (as
determined by invasion into Nm-treated pRBCs) (see Table S3 in the supplemental
material), underscoring the importance of separately assessing speciﬁc receptors. In this
study, we have investigated the use of three major sialylated receptors and in so doing
have highlighted the lesser role of GPC compared with GPA or GPB. The minor role of
the EBA-140/GPC invasion pathway, especially in laboratory strains, is in concordance
with other studies (21, 23). Knockout of the EBA-140 invasion ligand is facile in all
laboratory strains (9), and in contrast to knockouts of EBA-175, it does not lead to a
change in the use of ligand-receptor interactions (23). Jiang et al. showed that chymo-
trypsin treatment of GPA-null cells [En(a)] causes an almost complete block in
invasion by 10 P. falciparum laboratory strains (21). Both the EBA-175/GPA and the
EBA-140/GPC invasion pathways are chymotrypsin resistant, indicating minimal use of
the EBA-140/GPC invasion pathway in the absence of GPA (21). In addition, the limited
requirement of GPC for erythrocyte invasion can be viewed in light of the interaction
between the subtelomeric variant open reading frame protein (STEVOR) and GPC (63)
for the rosetting of parasite-infected erythrocytes, suggesting an additional role for this
erythrocyte receptor.
Recent studies have provided more evidence to demonstrate the importance of
deformability in the invasion process (64, 65). We did not measure deformability of KD
cRBCs; however, it is unlikely that changes in deformability of cRBCs as a result of
receptor KDs account for the phenotypes of invasion of P. falciparum strains into KD
cRBCs. This is because GPA-null cells and GPB-null cells have deformability and mem-
brane mechanical stability similar to those of wild-type pRBCs (66), whereas GPC-null
cells reportedly have decreased membrane stability and deformability (66). However,
the majority of P. falciparum strains in this study had normal invasion into GPC KD
cRBCs.
Altogether, the genetic evidence presented in this study reveals that the GPB
invasion pathway is important for invasion by the strains tested. Our study provides the
impetus for a more detailed investigation into the use of GPB by alternative invasion
ligands and the use of EBL-1 in invasion by ﬁeld isolates, both of which could contribute
to the dominance of GPB as a receptor in the hierarchy of the RBL and EBL invasion
ligands.
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MATERIALS AND METHODS
Bioinformatic analyses. A set of 314 host genes with known or potential roles in parasite invasion
was deﬁned by combining erythroblast-speciﬁc genes from HaemAtlas (38) with blood group genes from
the International Society of Blood Transfusion (http://www.isbtweb.org/). Whole-blood raw transcrip-
tomic data from 61 healthy Beninese children (36) were obtained from the Gene Expression Omnibus
(GSE34404). Two hundred thirty-eight genes from the erythroblast-speciﬁc/blood group set deﬁned
above are expressed in the Benin data set. This subset was background corrected using the detection P
value and quantile normalized using limma (67). The 95th to 5th quantile ratios were calculated to
identify the most variable transcripts.
Ex vivo culture of erythrocytes. A total of 3  105 to 10  105 bone marrow-derived CD34
hematopoietic stem cells (HSCs) (Lonza) or CD34 cells derived from peripheral blood of granulocyte
colony-stimulating factor (G-CSF)-stimulated donors (obtained from the HSCI-Boston Children’s Hospital
FACS Core) were cultured in Iscove’s modiﬁed Dulbecco’s medium (IMDM) (Biochrom) supplemented
with glutamine (Sigma-Aldrich), holo-human transferrin (Scipac), recombinant human insulin (Sigma-
Aldrich), heparin Choay (USBioAnalyzed), and 5% solvent/detergent virus-inactivated plasma (Octaplas;
Octapharma) as described previously (68) with the following modiﬁcations. On day 6 or 7, cells were
transduced with lentivirus harboring short hairpin RNA (shRNA) against GYPA (clone TRCN0000116453),
GYPB (clone TRCN0000084081), or GYPC (clone TRCN0000083398) or with the empty vector (pLKO).
Lentiviral particles were either prepared as previously described (37) or obtained from the RNAi Platform
(Broad Institute). Transduction and subsequent selection on 2 g/ml puromycin dihydrochloride (Sigma-
Aldrich) were performed as described previously (69). From day 12 or 13 to day 18, cells were cocultured
on a murine MS-5 stromal cell layer at a cell density of 3 105 to 6 105 cells/ml as described previously
(70, 71). On day 18, cells were replated on a fresh MS-5 stromal cell layer. Cells were harvested on either
day 17 or 18 or day 20 and passed through a 5-m Supor ﬁlter (Pall) to remove residual nucleated cells.
Filtered, enucleated cells were stored at 4°C in incomplete RPMI (RPMI 1640 [Sigma-Aldrich] supple-
mented with 25 mM HEPES and 50 mg liter1 hypoxanthine) until use in subsequent experiments.
Flow cytometry-based measurement of erythrocyte receptor expression. Erythrocytes were
washed three times in phosphate-buffered saline (PBS)–3% bovine serum albumin (BSA) blocking buffer,
pelleted in a 96-well plate at 5 105 erythrocytes per well (cultured erythrocytes) or 1 106 erythrocytes
per well (peripheral erythrocytes), and ﬁnally resuspended in 50 l (cultured erythrocytes) or 100 l
(peripheral erythrocytes) of PBS–3% BSA or the appropriate antibody solution. The following antibodies
were used at the indicated dilutions: phycoerythrin (PE)-conjugated anti-DARC (1:10) (Miltenyi Biotec),
anti-CD71-PE (1:10) (Miltenyi Biotec), ﬂuorescein isothiocyanate (FITC)-conjugated anti-GPA (1:50) (clone
2B7; Stem Cell Technologies), anti-GPC-FITC (1:500) (BRIC 10; Santa Cruz), anti-band 3-FITC (1:100) (BRIC
6-FITC; International Blood Group Reference Laboratory [IBGRL]), anti-BSG (1:1,000) (clone MEM-M6/6;
Axxora [Exbio]), anti-CR1 (1:200) (Santa Cruz), anti-DAF (1:3,000) (BRIC 216; IBGRL), anti-RhD (1:20)
(BRAD3-FITC; IBGRL), and anti-GPA/B (1:8,000) (clone E3; Sigma-Aldrich). To measure GPB expression,
erythrocytes were treated with 1 mg/ml trypsin (Sigma-Aldrich) to remove GPA before incubation in the
GPA/B antibody. For measurement of GPA and GPC expression in Senegal, the following probes were
used in addition to the aforementioned antibodies: for anti-GPA, BRIC 256 IgG (IBGRL; 1:100,000) and
BRIC 256-FITC Fab fragment (1:20); for anti-GPC, BRIC 10 IgG (IBGRL; 1:500,000), BRIC 10-FITC Fab
fragment (1:100), and BRIC 4 IgG (IBGRL; 1:8,000). Fab fragments were produced from whole IgG by
papain digestion (Pierce Fab preparation kit; Thermo Scientiﬁc) and FITC labeled (ProtOn ﬂuorescein
labeling kit; Vector Laboratories), followed by extensive dialysis in PBS.
Cells were incubated for 1 h at room temperature and washed three times in blocking buffer.
Unstained cells and cells stained with directly conjugated antibodies were resuspended in 100 l PBS for
analysis on a MACSQuant ﬂow cytometer (in Boston [Miltenyi Biotec]) or a BD FACSCalibur (in Senegal
[BD Biosciences]). Erythrocytes incubated with all other antibodies were then incubated in anti-mouse
IgG-Alexa Fluor 488 (1:1,000; Life Technologies) for 30 min at room temperature. Control samples with
no prior antibody incubation were incubated in either anti-mouse IgG2a-PE (1:10; Miltenyi Biotec) or
anti-mouse IgG-Alexa Fluor 488. Cells were washed twice and subjected to ﬂow cytometric analyses. The
data were analyzed using FlowJo 4 v. 10.0.7 for ﬂow cytometry done in Boston or FlowJo v. 8.8.6 for ﬂow
cytometry done in Senegal.
Quantitative cell surface proteomics. pLKO control, GPA KD, GPB KD, and GPC KD cultured
erythrocytes (cRBCs) were prepared as described above. The following sets of cells were labeled by
aminooxy-biotin as described previously (72, 73): pLKO cRBCs, 10.2  106 cells (in duplicate); GPA KD
cells, 16.2  106 cells; GPB KD cells, 3.5  106 cells; GPC KD cells, 11.2  106 cells; and peripheral RBCs,
10.0  106 cells (in duplicate).
Brieﬂy, surface sialic acid residues were oxidized with sodium meta-periodate (Thermo Scientiﬁc) and
then biotinylated with aminooxy-biotin (Biotium). The reaction was quenched, and the biotinylated cells
were incubated in a 1% Triton X-100 lysis buffer. Biotinylated glycoproteins were enriched with
high-afﬁnity streptavidin-agarose beads (Pierce) and washed extensively. Captured protein was dena-
tured with dithiothreitol (Sigma-Aldrich), alkylated with iodoacetamide (IAA) (Sigma-Aldrich), and di-
gested on-bead with trypsin (Promega) in 200 mM HEPES (pH 8.5) for 3 h. Tryptic peptides were collected
and labeled using tandem mass tag (TMT) reagents (Thermo Scientiﬁc). The reaction was quenched with
hydroxylamine and TMT-labeled samples were combined in a 1:1:1:1:1:1:1 ratio. Labeled peptides were
enriched and desalted, and then 6% of the total sample was subjected to mass spectrometry.
Mass spectrometry data were acquired using an Orbitrap Fusion coupled with an UltiMate 3000 Nano
LC (Thermo Scientiﬁc). Peptides were separated on a 75-cm PepMap C18 column (Thermo Scientiﬁc).
Peptides were separated using a 180-min gradient of 3 to 33% acetonitrile in 0.1% formic acid at a ﬂow
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rate of 200 nl/min. Each analysis used a MultiNotch MS3-based TMT method (72, 73). The scan sequence
began with an MS1 spectrum (Orbitrap analysis; resolution of 120,000, 400 to 1,400 Th, automatic gain
control [AGC] target of 2  105, and maximum injection time of 50 ms). MS2 analysis consisted of
collision-induced dissociation (CID) (quadrupole ion trap analysis; AGC of 15,000, normalized collision
energy [NCE] of 35, and maximum injection time of 120 ms). The top 10 precursors were selected for MS3
analysis, in which precursors were fragmented by higher-energy collisional dissociation (HCD) prior to
Orbitrap analysis (NCE of 55, maximum AGC of 2  105, maximum injection time of 150 ms, isolation
speciﬁcity of 0.5 Th, and resolution of 60,000).
Sample collection for ex vivo invasion assays and erythrocyte receptor expression. Collection of
clinical isolates and their experimental use were approved by the Ethics Committee of the Ministry of
Health in Senegal and by the Institutional Review Board of the Harvard T.H. Chan School of Public Health.
Sample collection was done in November 2013, toward the end of the transmission season in Senegal.
After informed consent from patients presenting with uncomplicated malaria in Thies, Senegal,4 ml of
whole blood was collected from each patient in sodium citrate Vacutainers and transported to Dakar,
Senegal. Samples arrived in the laboratory within 6 h of draw, and after washes in incomplete RPMI and
removal of the buffy coat, a fraction of parasitized cells was treated with Vibrio cholerae neuraminidase
(Sigma-Aldrich), chymotrypsin (Worthington), and trypsin and placed in culture conditions until invasion
assay setup.
For measurement of erythrocyte receptor expression in healthy Senegalese, 2 to 3 ml of whole blood
was collected from healthy donors from the Senegalese National Blood Transfusion Center in Dakar,
Senegal. Flow cytometry was performed on the day of blood collection.
Parasite cultures. P. falciparum cultures were maintained in human O erythrocytes. Parasites were
grown at 2% hematocrit (HCT) in complete RPMI medium (incomplete RPMI supplemented with 2.57 mM
sodium bicarbonate [Sigma-Aldrich], 0.25% AlbuMAX II [Life Technologies], plus 0.25% AB serum [for ex
vivo cultures] or 0.5% AlbuMAX II [for laboratory strains and the short-term culture-adapted strain]).
Cultures were kept at 37°C in a modulator incubator chamber gassed with 1% O2, 5% CO2, and 94% N2.
Enzyme treatments. Ring-stage parasite cultures were washed three times in incomplete RPMI and
treated with 1 mg/ml trypsin, 1 mg/ml chymotrypsin, and 66.7 mU/ml of Vibrio cholerae neuraminidase
for 1 h at 37°C with gentle mixing. Enzyme-treated cells were then washed twice in incomplete RPMI and
once in complete RPMI and then resuspended at 2% HCT in complete RPMI and placed in culture.
Invasion assays. Invasion assays were performed in half-area 96-well plates in duplicate or triplicate.
At the late trophozoite or schizont stage, the parasite culture was resuspended and adjusted to 0.5% HCT
based on hemocytometer cell counts (for ex vivo invasion assays in Senegal) or based on volume (for
invasion assays conducted in Boston). GPA, GPB, and GPC KD cultured erythrocytes (cRBCs) and pLKO
cRBCs were adjusted to 0.5% HCT based on hemocytometer cell counts. Parasitized cells were added to
cRBCs at an 80:20 ratio (Fig. 4B). For ex vivo invasion assays in Senegal, 10 l of the total sample volume
of 40 l was used for smears to determine the starting parasitemia by light microscopy. Boston-based
invasion assays were performed with a total sample volume of 30 l. Assays were harvested at 30 to 40 h
after setup by making smears or cytospin preparations, which were stained with May-Grünwald and
Giemsa stains to determine the ﬁnal parasitemia by light microscopy. Five hundred to 2,000 erythrocytes
were counted, depending on the experiment. The invasion efﬁciency based on ﬁnal parasitemia was
determined for each strain after normalization to pLKO control cells.
Statistical analyses. Univariate analyses were performed using GraphPad Prism v. 5.0 for Mac OS X.
Signiﬁcant differences between each knockdown group and control group were determined using a
one-way analysis of variance (ANOVA) and Dunnett’s multiple-comparison test.
Data analysis for quantitative surface proteomics. Mass spectra were processed using a Sequest-
based in-house software pipeline as previously described (74). Data were searched using the human
UniProt database (April 2014) concatenated with common contaminants and ﬁltered to a ﬁnal protein-
level false-discovery rate of 1%. Proteins were quantiﬁed by summing TMT reporter ion counts across all
peptide-spectral matches using in-house software as previously described (74), excluding peptide-
spectral matches with poor-quality MS3 spectra (a combined signal/noise ratio of less than 250 across all
TMT reporter ions). For protein quantitation, reverse and contaminant proteins were removed.
A subset of 78 membrane proteins were identiﬁed based on the presence of criteria extracted from
the UniProt (75) database (type I/II/III/IV transmembrane domain, multipass transmembrane domain,
glycosylphosphatidylinositol [GPI] anchored, or lipid anchored) or on predictions of transmembrane
helices based on the TMHMM 2.0 program (76, 77). Each reporter ion channel was summed across all 78
proteins and normalized assuming equal protein loading across all samples. To compare the relative
abundances of the membrane proteins between the pLKO cRBCs and KD cRBCs, proteins with a
coefﬁcient of variation of 	0.25 in the pLKO technical replicates were excluded from further analysis.
The fold change for each protein was calculated as the ratio of the signal/noise ratio for GPA/B/C KD
to the average signal/noise ratio for pLKO controls. P values (signiﬁcance A) were calculated using
Perseus v. 1.5.1.6 and adjusted with the Benjamini-Hochberg method (78). To compare the abundance
of plasma membrane proteins between pLKO cRBCs and peripheral RBCs, for each protein the normal-
ized signal for each reporter channel was renormalized to a total of 1, and the data were clustered using
the k-means algorithm in Cluster v. 3.0 with a Euclidean distance metric (79) and subsequently displayed
using TreeView v. 1.1.6r4 (80).
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